Medical Science News

RSS

Mayo Clinic study reveals brain cell deficit behind Tourette syndrome

A new Mayo Clinic study finds that people with Tourette syndrome have about half as many of a specific type of brain cell that helps calm overactive movement signals as people without the condition.

22 Apr 2025

Targeting zombie cells could revolutionize chronic back pain treatment

In a preclinical study led by McGill University researchers, two drugs targeting "zombie cells" have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide.

22 Apr 2025

Study shows how alcohol combined with burn trauma throws the intestinal microbiome into chaos

What happens in your gut after a night of heavy drinking and a severe burn injury? According to a new study, it might involve more than just pain and discomfort.

22 Apr 2025

New insights show why dopamine detox trend is overly simplistic

Dopamine is the brain's motivational spark, driving us to chase what feels good, say scrolling another reel on social media, and steer clear of what doesn't, like touching a hot stove.

22 Apr 2025

Dr. Jeremie Poschmann's data-driven approach to immunology and translational science

In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind his bold, data-centric approach to immunology and translational science.

22 Apr 2025

New noninvasive method for early diabetes risk detection

The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early and spare you a needle prick or two.

22 Apr 2025

Owlstone Medical announces investment of up to $2.3 million USD from the Cystic Fibrosis Foundation to develop a breath test for Pseudomonas aeruginosa detection in cystic fibrosis patients

Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced that the Cystic Fibrosis Foundation has made an up to USD $2.3 million equity investment (circa £1.7 million) in Owlstone to develop a breath test for Pseudomonas aeruginosa (PA) detection in patients with cystic fibrosis (CF).

22 Apr 2025

Study offers insight into how the brain handles multiple pieces of information

A new study offers insight into what is happening in our brains when our working memory must use its limited resources to remember multiple things.

21 Apr 2025

Plastic additives found in 85% of foods raise concern for infant health

Researchers assessed plasticizer levels in foods typical of the Spanish diet and found widespread contamination, with infants showing the highest exposure. Certain additives, like DEHP, exceeded safety thresholds in high-exposure scenarios.

21 Apr 2025

Pilocarpine eye drops improve outcomes after Kahook Dual Blade goniotomy surgery

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new research published by faculty members and trainees in the Department of Ophthalmology at the University of Colorado School of Medicine.

21 Apr 2025

New RNA-based blood test offers insight into cancer and tissue damage

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions.

21 Apr 2025

Discovery solves 67-year-old biochemical mystery about vitamin B1

Chemists have confirmed a 67-year-old theory about vitamin B1 by stabilizing a reactive molecule in water - a feat long thought impossible.

21 Apr 2025

Blood test detects early Alzheimer’s signs in people with memory concerns

A new study confirms that plasma p-tau181 levels can identify subjective cognitive decline (SCD) as a distinct early stage of Alzheimer’s disease. This biomarker predicts cognitive decline and clinical progression, offering potential for early diagnosis and trial stratification.

21 Apr 2025

Major breakthrough could turn IV drugs into oral treatments for brain cancer and Alzheimer's

A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral treatments for diseases like brain cancer and Alzheimer's disease.

21 Apr 2025

Researchers find immune system proteins involved in severe cases of schistosomiasis

New insights into the mechanisms that cause more severe cases of schistosomiasis - a disease caused by parasitic worms and second only to malaria in terms of potential harm - have been revealed by researchers at Penn State.

21 Apr 2025

iPS cell transplants show early promise for treating Parkinson's disease safely

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with Parkinson’s disease and observed promising motor improvements with no serious safety concerns over 24 months. The therapy showed increased dopamine synthesis without tumor formation or graft-induced dyskinesia.

21 Apr 2025

Engineered brain cells offer new hope for treating Alzheimer's

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to University of California, Irvine scientists.

21 Apr 2025

Fruit fly study reveals key brain proteins that help prevent seizures

One in ten people will have at least one seizure in their life, but effective treatments for seizures remain very limited, in part due to incomplete understanding of the brain mechanisms involved.

21 Apr 2025

Vitamin D curbs colorectal cancer by boosting immunity and blocking tumor growth

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor progression to help prevent colorectal cancer (CRC). Evidence suggests adequate vitamin D levels and supplementation reduce CRC risk and improve outcomes.

21 Apr 2025

Study reveals the rising popularity of Tusi in NYC nightclubs

"Tusi", also known as "tucibí" or "pink cocaine", is a drug concoction that emerged in Latin America and Europe within the past decade and is becoming increasingly popular in the USA.

21 Apr 2025